SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/D056E75F7A3FD73377F1C479459AC9FEC6C3BB930F4881CE156D52D137BC09FBE545FAEE4CFDB36183FDC48B5E185B99>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/D056E75F7A3FD73377F1C479459AC9FEC6C3BB930F4881CE156D52D137BC09FBE545FAEE4CFDB36183FDC48B5E185B99
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/D056E75F7A3FD73377F1C479459AC9FEC6C3BB930F4881CE156D52D137BC09FBE545FAEE4CFDB36183FDC48B5E185B99
http://www.w3.org/2000/01/rdf-schema#comment
"Our findings provide new clues regarding the role of ACTR as a prospective sensitizing target for sorafenib therapy in hepatocellular carcinoma"
xsd:string
http://purl.uniprot.org/uniprot/#_7BA9DA72EE9E448867C40B21385F0CA0E62D6F8B89497EC60965889F899208F57F207BDF03411D6CB43D09BF8082813A
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/D056E75F7A3FD73377F1C479459AC9FEC6C3BB930F4881CE156D52D137BC09FBE545FAEE4CFDB36183FDC48B5E185B99
http://purl.uniprot.org/uniprot/B4DYS9
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/D056E75F7A3FD73377F1C479459AC9FEC6C3BB930F4881CE156D52D137BC09FBE545FAEE4CFDB36183FDC48B5E185B99
http://purl.uniprot.org/uniprot/#_B4DYS9-mappedCitation-32279388
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/D056E75F7A3FD73377F1C479459AC9FEC6C3BB930F4881CE156D52D137BC09FBE545FAEE4CFDB36183FDC48B5E185B99